GCAP‐II: Isolation and characterization of the circulating form of human uroguanylin

Authors:
  • MKMichaela Kuhn
    Michaela Kuhn
  • PSPeter Schulz-Knappe
    Peter Schulz-Knappe
  • MRManfred Raida
    Manfred Raida
  • MFMartin Fuchs
    Martin Fuchs
  • JKJoachim Klodt
    Joachim Klodt
  • KAKnut Adermann
    Knut Adermann
  • VKVolkhard Kaever
    Volkhard Kaever
  • YCYalcin Cetin
    Yalcin Cetin
  • WFWolf-Georg Forssmann
    Wolf-Georg Forssmann

Abstract
The systematic isolation of circulating regulatory peptides which generate cGMP as second messenger resulted in the identification of a novel member of the guanylin family. In the present study we describe the purification and amino acid sequence of a new guanylate cyclase C activating peptide (GCAP-II). GCAP-II contains 24 amino acids in the following sequence: FKTLRTIANDDCELCVNVACTGCL. Its molecular mass is 2597.7 Da. The 16 C-terminal amino acids are identical to uroguanylin from human urine. Native and synthetic GCAP-II activate GC-C, the specific guanylate cyclase receptor, of cultured human colon carcinoma (T84) cells. GCAP-II stimulates chloride secretion in isolated human intestinal mucosa mediated by intracellular cGMP increase. GCAP-II specific antibodies were used to localize the peptide by immunohistochemistry in entero-endocrine cells of the colonic mucosa

This publication has 8 references indexed in Scilit: